A PYMNTS Company

US: Antitrust suit filed against maker of Mucinex

By  |  February 8, 2015

Mutual Pharmaceutical Company and United Research Laboratories filed an antitrust suit against Reckitt Benckiser on Friday alleging unfair trade practices in the sale and distribution of Mucinex.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The plaintiffs allege Reckitt wrongfully monopolized the market for Mucinex. Reckitt allegedly deliberately blocked the formation of a competitive market for the manufacture and sale of a generic version of the drug.

    The suit alleges that Reckitt has failed to provide ERG to Mutual since October 2013 when another company began selling a generic version of the drug. The plaintiffs are seeking an injunction to prevent Reckitt’s alleged monopolistic practices.

     

    Full Content: The Pennsylvania Record

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.